Cardio Diagnostics Holdings Inc
CDIO3.620USD
-0.360-9.05%
Handelsschluss 11/04, 16:00（ET）Kurse um 15 Minuten verzögert
6.30MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Cardio Diagnostics Holdings Inc Unternehmen
Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.
Cardio Diagnostics Holdings Inc Informationen
BörsenkürzelCDIO
Name des UnternehmensCardio Diagnostics Holdings Inc
IPO-datumNov 23, 2021
CEODr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Anzahl der mitarbeiter13
WertpapierartOrdinary Share
GeschäftsjahresendeNov 23
Addresse311 W. Superior Street
StadtCHICAGO
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl60645
Telefon18552269991
Website
BörsenkürzelCDIO
IPO-datumNov 23, 2021
CEODr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Führungskräfte von Cardio Diagnostics Holdings Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
4.28K
--
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
3.87K
+0.03%
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
3.25K
+0.03%
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
2.39K
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Wendy J. Betts
Ms. Wendy J. Betts
Independent Director
Independent Director
--
--
Mr. Peter K. Fung
Mr. Peter K. Fung
Independent Director
Independent Director
--
--
Mr. Paul F. Burton, J.D.
Mr. Paul F. Burton, J.D.
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
4.28K
--
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
3.87K
+0.03%
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
3.25K
+0.03%
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
2.39K
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Umsatzaufteilung
Keine Daten
Keine Daten
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Thu, Oct 2
Aktualisiert: Thu, Oct 2
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Dogan (Meeshanthini)
3.13%
Bd Holding, Inc
3.00%
BlackRock Institutional Trust Company, N.A.
2.02%
Geode Capital Management, L.L.C.
0.76%
Susquehanna International Group, LLP
0.74%
Andere
90.35%
Aktionäre
Aktionäre
Anteil
Dogan (Meeshanthini)
3.13%
Bd Holding, Inc
3.00%
BlackRock Institutional Trust Company, N.A.
2.02%
Geode Capital Management, L.L.C.
0.76%
Susquehanna International Group, LLP
0.74%
Andere
90.35%
Aktionärstypen
Aktionäre
Anteil
Individual Investor
4.04%
Investment Advisor
3.61%
Corporation
3.00%
Investment Advisor/Hedge Fund
0.76%
Research Firm
0.43%
Hedge Fund
0.01%
Andere
88.15%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
39
84.84K
4.81%
-17.80K
2025Q2
44
210.46K
12.10%
-12.90K
2025Q1
46
215.87K
12.62%
-11.61K
2024Q4
51
6.58M
12.62%
+556.91K
2024Q3
70
5.72M
21.51%
-4.06M
2024Q2
76
5.70M
26.20%
-6.56M
2024Q1
73
5.54M
28.62%
-6.62M
2023Q4
73
5.55M
28.89%
-5.24M
2023Q3
68
4.28M
41.11%
-6.26M
2023Q2
64
4.02M
40.37%
-6.37M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Dogan (Meeshanthini)
55.18K
3.13%
--
--
Aug 25, 2025
Bd Holding, Inc
52.88K
3%
--
--
Aug 25, 2025
BlackRock Institutional Trust Company, N.A.
35.57K
2.02%
-2.00
-0.01%
Jun 30, 2025
Geode Capital Management, L.L.C.
13.37K
0.76%
+198.00
+1.50%
Jun 30, 2025
Susquehanna International Group, LLP
13.06K
0.74%
+13.06K
--
Jun 30, 2025
The Vanguard Group, Inc.
12.68K
0.72%
+265.00
+2.13%
Jun 30, 2025
RBC Capital Markets Wealth Management
7.50K
0.43%
+7.50K
--
Jun 30, 2025
Dogan (Timur)
4.28K
0.24%
--
--
Aug 25, 2025
Hosseinion (Warren)
3.87K
0.22%
+1.00
+0.03%
Aug 25, 2025
Philibert (Robert)
3.25K
0.18%
+1.00
+0.03%
Aug 25, 2025
Mehr Anzeigen
Verbundene ETFs
Name
Anteil
Keine Daten
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
